Association and multimodal model of retinal and blood‐based biomarkers for detection of preclinical Alzheimer’s disease
Swetha Ravichandran, Peter J. Snyder, Jessica Alber, Andreas Jeromin, Lauren E Chaby, Edmund Arthur · 2025
Read Association and multimodal model of retinal and blood‐based biomarkers for detection of preclinical Alzheimer’s disease by Swetha Ravichandran, Peter J. Snyder, Jessica Alber, Andreas Jeromin, Lauren E Chaby, Edmund Arthur (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716755.txt.
Description
Swetha Ravichandran and co-authors test whether eye and blood markers together can flag preclinical Alzheimer's disease, in a 2025 paper. Blood ratios and proteins tied to amyloid and nerve damage are promising early signals. The retina, as a window on the brain, may add its own clues before symptoms appear.
The study drew 81 cognitively healthy adults, averaging sixty-seven years old, from a retinal imaging study of Alzheimer's disease. Blood tests measured amyloid ratio and three marker proteins, while eye scans captured retinal surface changes and nerve fiber thickness. A subgroup of fifty-seven eyes fed a combined model separating preclinical disease from controls. Linking the two marker families could sharpen silent-stage detection.
Catalog record
| CREATOR | Swetha Ravichandran, Peter J. Snyder, Jessica Alber, Andreas Jeromin, Lauren E Chaby, Edmund Arthur |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |